IL104238A - Thiazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Thiazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL104238A
IL104238A IL10423892A IL10423892A IL104238A IL 104238 A IL104238 A IL 104238A IL 10423892 A IL10423892 A IL 10423892A IL 10423892 A IL10423892 A IL 10423892A IL 104238 A IL104238 A IL 104238A
Authority
IL
Israel
Prior art keywords
compound
group
formula
carbon atoms
thiazolidine
Prior art date
Application number
IL10423892A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL104238A publication Critical patent/IL104238A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10423892A 1991-12-26 1992-12-25 Thiazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same IL104238A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34457191 1991-12-26

Publications (1)

Publication Number Publication Date
IL104238A true IL104238A (en) 1996-10-31

Family

ID=18370304

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10423892A IL104238A (en) 1991-12-26 1992-12-25 Thiazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (21)

Country Link
EP (1) EP0549365B1 (fr)
JP (1) JP2833949B2 (fr)
CN (1) CN1032751C (fr)
AT (1) ATE126221T1 (fr)
AU (1) AU654223B2 (fr)
CA (1) CA2086277A1 (fr)
CZ (1) CZ389792A3 (fr)
DE (1) DE69204041T2 (fr)
DK (1) DK0549365T3 (fr)
ES (1) ES2078671T3 (fr)
FI (1) FI925849A7 (fr)
GR (1) GR3017632T3 (fr)
HK (1) HK196095A (fr)
HU (1) HU215450B (fr)
IL (1) IL104238A (fr)
MX (1) MX9207595A (fr)
NO (1) NO302471B1 (fr)
NZ (1) NZ245612A (fr)
RU (1) RU2095354C1 (fr)
TW (1) TW211007B (fr)
ZA (1) ZA9210021B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
NO305987B1 (no) * 1994-04-11 1999-08-30 Sankyo Co Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
EP0783888A1 (fr) * 1995-12-26 1997-07-16 Sankyo Company Limited Utilisation de la troglitazone et de thiazolidinediones apparentées dans la fabrication d'un médicament destiné au traitement et la prévention de l'ostéoporose
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
DE19828114A1 (de) * 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de) * 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19926233C1 (de) * 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
ATE310733T1 (de) * 2000-04-21 2005-12-15 Pfizer Prod Inc Thyroid-rezeptorliganden
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2001259130A1 (en) * 2000-04-24 2001-11-07 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法
WO2007109037A2 (fr) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Analogues de thiazolidinedione
UA96441C2 (ru) 2006-03-16 2011-11-10 Метаболик Солюшнз Девелопмент Компани Фармацевтическая композиция, которая содержит аналог тиазолидиндиона митоглитазон, для лечения заболеваний, опосредованных метаболическим воспалением
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
KR101537830B1 (ko) * 2007-09-14 2015-07-17 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 고혈압 치료용 티아졸리딘디온 유사체
RU2564661C2 (ru) 2009-12-15 2015-10-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
MX2012012092A (es) * 2010-04-19 2012-12-17 Metabolic Solutions Dev Co Llc Sintesis novedosa para compuestos de tiazolidinadiona.
AU2011242844A1 (en) * 2010-04-21 2012-11-01 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues
KR101988203B1 (ko) 2010-08-10 2019-06-11 씨리우스 테라퓨틱스, 엘엘씨 티아졸리딘디온 화합물의 신규한 합성법
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat

Also Published As

Publication number Publication date
NO302471B1 (no) 1998-03-09
ATE126221T1 (de) 1995-08-15
HU9204130D0 (en) 1993-04-28
CZ389792A3 (en) 1994-01-19
TW211007B (fr) 1993-08-11
CN1074680A (zh) 1993-07-28
CA2086277A1 (fr) 1993-06-27
EP0549365A1 (fr) 1993-06-30
JP2833949B2 (ja) 1998-12-09
GR3017632T3 (en) 1996-01-31
RU2095354C1 (ru) 1997-11-10
EP0549365B1 (fr) 1995-08-09
HK196095A (en) 1996-01-05
NO924964D0 (no) 1992-12-22
ES2078671T3 (es) 1995-12-16
FI925849A7 (fi) 1993-06-27
AU3043192A (en) 1993-07-01
MX9207595A (es) 1994-06-30
ZA9210021B (en) 1993-07-02
DE69204041T2 (de) 1996-03-28
NZ245612A (en) 1994-06-27
JPH05239041A (ja) 1993-09-17
CN1032751C (zh) 1996-09-11
HU215450B (hu) 1999-04-28
DK0549365T3 (da) 1995-12-18
HUT67788A (en) 1995-04-28
DE69204041D1 (de) 1995-09-14
NO924964L (no) 1993-06-28
AU654223B2 (en) 1994-10-27
FI925849A0 (fi) 1992-12-23

Similar Documents

Publication Publication Date Title
IL104238A (en) Thiazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
EP0139421B1 (fr) Dérivés de la thiazolidine, leur préparation et composition les contenant
US5143930A (en) Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
US7109222B2 (en) Compounds that modulate PPAR activity and methods of preparation
CA2086179C (fr) Composes de thiazolidine contenant un groupe quinone, leur preparation et leurs utilisations a des fins therapeutiques
US20030207916A1 (en) Compounds that modulate PPAR activity and methods of preparation
CZ176393A3 (en) Oxazolidine derivatives, process of their preparation and pharmaceutical preparations in which they are comprised
HK1007050B (en) Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses
IL96654A (en) Hydroxybenzyl substituted sulfur containing heterocyclic derivatives their preparation and pharmaceutical compositions containing them
US7521465B2 (en) Diphenyl ether derivatives
EP0214732A2 (fr) Composés hétérocycliques substitués par un radical benzylthio substitué ayant une activité antagoniste de leukotriènes
EP0714893A1 (fr) Dérivés du benzothiazole substitués en position 2 utiles dans le traitement de complications du diabète
FR2621038A1 (fr) Derives d'alcadienes, leurs preparations, les medicaments les contenant et produits intermediaires
EP0091761B1 (fr) Dérivés de thiazolidine et leur préparation
FR2662160A1 (fr) Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.
BE897156A (fr) Derives du dithioiane, leur preparation et leur utilisation
EP0112620B1 (fr) Hydantoines-5-(phényl substitués)
US5180730A (en) Heterocyclic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force